DV
Dividend Vision

CTSO — Cytosorbents Crp

Cytosorbents Crp (CTSO)

Total return is -99.5% over the past 20 years, 879.5 points behind SPY at 780.0%. Its deepest 1-year drawdown was 69.8%.

CTSO is an individual stock rather than a diversified ETF, representing a single equity holding in CytoSorbents Corporation, a healthcare company. As a single-stock position, it does not currently offer dividend distributions and carries no ongoing expense ratio typical of managed funds. This holding appeals primarily to investors seeking direct equity exposure to a specific company rather than those pursuing diversified dividend income strategies.

CTSO key facts

Asset type
Stock
Asset class
Equity
Inception date
08/08/2006
Last close
$0.40
Market cap
$22,623,390
Average volume
66600.0
Beta
1.391
Payout ratio
0.0
Forward P/E
7.1994
EPS
$-0.19